Dr. Daniel Cameron

by Daniel J. Cameron, MD MPH Study examines doxycycline as cause of acute pancreatitis in patient initially treated for suspected Lyme disease. A 51-year-old man was admitted to the hospital with a one-week history of extreme fatigue, malaise, and confusion. Three days prior to admittance, the man had started oral doxycycline for presumed Lyme disease […]

by Daniel J. Cameron, MD MPH A recent discovery by researchers at Mayo Clinic demonstrates the complexity of tick-borne organisms. Pathologists at the institution have described a new Borrelia burgdorferi sensu lato genospecies in six patients. The new species, provisionally named Borrelia mayonii, was found in the Upper Midwest but it may be elsewhere. Symptoms are

by Daniel J. Cameron, MD MPH According to a paper published this week in Parasites & Vectors, “larval bites on humans, which easily go unnoticed, can cause Lyme borreliosis and Borrelia miyamotoi disease.” Researchers found that larvae of Ixodes ricinus can transmit Borrelia afzelii and B. miyamotoi to rodents. [1] Individuals living in the Netherlands

by Daniel J. Cameron, MD MPH Although Lyme disease and the Zika virus are transmitted by different types of vectors, both illnesses can cause severe, long-term health damage and are of enormous concern to the general public. The response by the Centers for Disease Control and Prevention (CDC) to each threat, however, has been decidedly

by Daniel J. Cameron, MD MPH A study by Nimgaonkar and colleagues examines the relationship between cognitive deficits and infectious agents. The authors found a temporal cognitive decline in patients with exposure to infectious agents in a population-based, aging cohort. [1] The authors reported that exposure to cytomegalovirus (CMV), Herpes Simplex virus, type 1 (HSV-1),

As many as one-third of patients with Lyme disease are ill on long-term follow-up. A population-based, retrospective cohort study in Massachusetts found 34% of patients suffered from arthritis or recurrent arthralgias, neurocognitive impairment, and neuropathy or myelopathy, an average of 6 years after treatment for Lyme disease. [1] Meanwhile, 62% of a cohort of 215 consecutively treated Lyme disease patients in

by Daniel Cameron, MD MPH Physicians, including Dr. Gary Wormser who operate the facility, recently published a review article, which states, “We have never seen the poorly defined entity referred to as Lyme encephalopathy and question its existence. We also question the existence of a diffuse axonal peripheral neuropathy as a manifestation of Lyme disease,

Italy. Google Search Trends on Lyme disease. 2011 – 2015. In 2015, Lyme disease stole the spotlight. Quite possibly, like never before. The disease made international headlines throughout the year, grabbing the attention of individuals around the world, as big-name celebrities and high-profile executives went public and opened up about their struggles with a disease that has been stuck

by Daniel J. Cameron, MD, MPH The risk of becoming infected with Babesia is rising. It’s common to find ticks and enzootic hosts carrying both Borrelia burgdorferi (the causative agent of Lyme disease) and Babesia microti. In fact, between 12% and 42% of rodents are co-infected with both agents. Up to 40% of patients with

by Daniel J. Cameron, MD, MPH The survey’s data should not come as a surprise. Twelve years ago, in 2004, while testifying before the Connecticut Public Health Department, the state’s chief epidemiologist Dr. James Hadler warned officials that “… roughly 1% of the entire population, or probably 34,000 people, are getting a diagnosis of Lyme disease